Biotech companies in the United States by P/B ratio

Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.

Biogen has the lowest figure of the 18 biotech companies in the United States ranked by P/B ratio, at 2.0, followed by Vaxcyte (3.4) and Neurocrine Biosciences (4.0). Figures as of 20 Nov 2026, 19:35 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
18
Lowest
Biogen2.0
Median
8.3
Combined market value
SAR 2.74T
Countries
1
Not ranked
2no P/B ratio on file

Market values as of .

United States
All sectors
Biotech
SAR
Clear filters
Biotech companies in the United States by P/B ratio
#CompanyP/B ↑Market capPriceToday1 yearPrice, 30 daysCountry
1BiogenBIIB · Health Care2.0SAR 138.5BSAR 936.71 1.04% up 41% up United States
2VaxcytePCVX · Health Care3.4SAR 33.4BSAR 210.83 3.70% down 22% up United States
3Neurocrine BiosciencesNBIX · Health Care4.0SAR 57.8BSAR 571.05 2.79% down 10% up United States
4RepligenRGEN · Health Care4.5SAR 39.6BSAR 618.88 3.12% down 5% up United States
5Bio-TechneTECH · Health Care5.3SAR 42.8BSAR 272.75 0.01% up 18% up United States
6Kymera TherapeuticsKYMR · Health Care6.1SAR 36.8BSAR 430.71 3.84% down 81% up United States
7Krystal BiotechKRYS · Health Care6.4SAR 34.6BSAR 1,168.55 1.37% down 49% up United States
8CG OncologyCGON · Health Care7.2SAR 27BSAR 301.81 1.77% down 93% up United States
9Twist BioscienceTWST · Health Care8.0SAR 26.6BSAR 390.76 6.68% down 291% up United States
10ExelixisEXEL · Health Care8.7SAR 59.7BSAR 244.86 0.85% down 55% up United States
11ImmunovantIMVT · Health Care10.0SAR 24.7BSAR 119.54 2.01% down 44% up United States
12ModernaMRNA · Health Care11.4SAR 292.8BSAR 723.57 3.24% down 740% up United States
13Revolution MedicinesRVMD · Health Care14.6SAR 131.8BSAR 609.43 1.89% up 125% up United States
14Gilead SciencesGILD · Health Care16.0SAR 781.2BSAR 629.79 0.81% up 31% up United States
15AmgenAMGN · Health Care16.5SAR 887.2BSAR 1,640.17 0.21% up 30% up United States
16Adaptive BiotechnologiesADPT · Health Care25.4SAR 16.8BSAR 104.07 1.11% down 51% up United States
17Scholar Rock HoldingSRRK · Health Care35.4SAR 22.4BSAR 183.84 2.71% down 25% up United States
18Kodiak SciencesKOD · Health Care500SAR 24BSAR 367.57 0.08% up 371% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7515 SAR). 2 companies have no P/B ratio on file and are not ranked here.

Questions and answers

Which biotech companies in the United States have the lowest P/B ratio?

Biogen (2.0), Vaxcyte (3.4) and Neurocrine Biosciences (4.0) have the lowest P/B ratio of the 18 biotech companies in the United States ranked here as of 20 Nov 2026, 19:35 UTC.

How many biotech companies in the United States are in this ranking?

18 are ranked by P/B ratio. 2 more have no P/B ratio on file and are left out rather than ranked at zero.

What are these biotech companies in the United States worth together?

The 18 biotech companies in the United States ranked by P/B ratio have a combined market value of SAR 2.74T as of 20 Nov 2026, 19:35 UTC.

What does ranking by P/B ratio measure?

Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.

Cite this page

Funkfolio, “Biotech companies in the United States by P/B ratio”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=pb-ratio

Underlying data: Yahoo Finance; SEC EDGAR.